INTERVIEW: Nexstim advances headstart in TMS stroke therapy
This article was originally published in Clinica
Executive Summary
Sometimes the most direct route is not necessarily the fastest or the best. This seems to be the case for Finnish company Nexstim, which has just kicked off a pivotal Phase III study of its Navigated Brain Therapy (NBT) system in the US.